Datroway joins Trodelvy for frontline TNBC in the EU
AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.
Discover a new era of healthcare panel engagement: Grounded ...
A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
Why pharma needs honest patient dialogue
Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.
From Alzheimer’s disease research to the real-world setting:...
In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.
Policy in Focus: What’s new with CMS drug price negotiation,...
Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.
What HCPs Say Pharma Gets Wrong About Survey Research
Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.
Inizio Launches Intelligent Congress to Turn Event Investmen...
Inizio, the leading global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals


